Beginning Cash: The amount of cash reported by the company on its previous statement.
Elite Pharmaceuticals Inc. (ELTP) had Beginning Cash of $11.77M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$40.21M |
|
$-5.88M |
|
$12.99M |
|
$27.23M |
|
$18.51M |
|
$21.70M |
|
$-22.26M |
|
$-0.56M |
|
$-0.56M |
|
$-5.88M |
|
$-5.88M |
|
$-5.88M |
|
$-5.88M |
|
$21.70M |
|
$22.21M |
|
1.07B |
|
1.07B |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$77.86M |
|
$10.27M |
|
$33.48M |
|
$111.34M |
|
$10.76M |
|
$4.16M |
|
$52.89M |
|
$63.66M |
|
$47.68M |
|
$42.04M |
|
$47.68M |
|
1.07M |
|
| Cash Flow Statement Financials | |
$14.78M |
|
$-0.22M |
|
$-4.13M |
|
|
Beginning Cash |
$11.77M |
$22.20M |
|
$10.43M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.23 |
|
-- |
|
-- |
|
0.08 |
|
0.10 |
|
67.71% |
|
53.96% |
|
53.96% |
|
-- |
|
-1.40% |
|
-14.63% |
|
$14.56M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
0.67 |
|
1.11 |
|
81.06 |
|
-12.34% |
|
-14.00% |
|
-5.29% |
|
-11.35% |
|
$44.65 |
|
$0.01 |
|
$0.01 |
|